|
|
|
| Enteral nutrition support on nutritional status in gastrointestinal cancer patients |
| 1Affliated Hospital of Hebei University of Engineering, Handan 056002, Hebei, China; 2Handan Central Hospital, Handan 056000, Hebei, China; 3Medical College of Hebei University of Engineering, Handan 056002, Hebei, China |
|
|
|
|
Abstract Objective To investigate the effect of enteral nutrition and parenteral nutrition on the nutritional status of patients with gastrointestinal cancer after operation. Methods Selected patients with gastrointestinal cancer in Affliated Hospital of Hebei University of Engineering and Handan Central Hospital from October 2016 to February 2018 evaluated the nutritional status by were using nutritional risk screening tool (NRS-2002) and scored patient-generate subjective global assessment (PG-SGA). The results showed that there were 200 patients with high nutritional risk. According to random number table method, the patients were divided into observation group and control group with 100 cases in each group. The control group were administrated parenteral nutrition treatment and the observation group were received enteral nutrition therapy. Results The incidence of complications in patients with no nutritional risk was 12.5% (27/216), and in patients with risk was 23% (46/200). The difference was statistically significant (P<0.05). Gender, mean age, mean body mass index (BMI), hemoglobin (HGB), total protein (TP), albumin (ALB), prealbumin (PA) and the types of cancer between two groups were l no statistical significance (all P>0.05). Two weeks after the nutritional therapy, hemoglobin (HGB), albumin (ALB) level of observation group were both significantly higher than those of the control group, and the difference was statistically significant (P<0.05). However, there was no statistical difference between the two groups of prealbumin (PA) and total protein (TP) (P>0.05). The incidence of complications in the study group was 8% and lower than that of the control group which was 19% (P<0.05). Conclusions The incidence of nutritional risk is high in patients with gastrointestinal cancer, which can lead to higher incidence of complications. Enteral nutrition therapy of patients with gastrointestinal cancer can effectively improve the nutritional status compared to parenteral nutrition treatment.
|
|
|
|
|
|
| [1] |
1FAN Yue-ping， 2ZHANG Tian， 2QU Qian-nuo， 3SHI Han-ping. Interpretation of expert consensus for nutritional therapy pathway of malignant tumor in China—peripheral venous catheterization[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 301-304. |
| [2] |
ZHAO Xiang，WANG Wen-jing. ONS improves nutritional status of esophageal cancer patients under radiotherapy treatment[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 357-360. |
| [3] |
CHENG Guo-wei， SUN Li， CHEN Ping， HE Xiang-ling， SU Dan， XI Heng-zhi， ZANG Ding-qi. Nasojejunal nutrition therapy improves the efficacy and decreased adverse reactions of radiotherapy for esophageal cancer patients[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 332-336. |
| [4] |
1，2GENG Bi-zhu, 1ZHENG Jin. Review of family nutrition support research during the intermission of chemotherapy[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 386-390. |
| [5] |
GAO Chun， LI Meng， WEI Jun-min， LI Yu-zhen， TIAN Wei-jun， JIANG Hai-ping， SHEN Wei， XU Ai-guo， YU Zhen， CHEN Dong-sheng， CHEN Lian-zhen， GUAN Wen-xian， JIANG Hua， LI Da-kui， MEI Dan， YU Ji-ren， ZHAO C. Expert consensus on clinical use of compound amino acid injection[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 183-189. |
| [6] |
CHANG Ge-yun. Immune enteral nutrition on advanced gastrointestinal cancer patients undergoing apatinib[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 230-235. |
|
|
|
|
